NASDAQ : UTMD

Utah Medical Products, Inc. — Financial statements

Healthcare · Medical Instruments & Supplies · United States

Last price 66.8 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 212.09M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Utah Medical Products, Inc. (UTMD) reported revenue of 34.92M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue34.92M38.52M40.90M50.22M52.28M49.05M
Cost of Revenue14.77M16.52M16.76M20.19M20.09M18.14M
Gross Profit20.14M22.00M24.14M30.04M32.20M30.92M
Selling, General & Admin7.52M8.58M7.60M12.70M11.91M11.51M
Research & Development661.00K668.00K813.00K560.00K493.00K526.00K
Operating Expenses8.18M9.24M8.41M13.26M12.41M12.04M
Operating Income11.96M12.76M15.73M16.78M19.79M18.88M
Interest & Investment Income2.81M2.81M3.37M3.04M661.00K166.00K
Currency Exchange Gain (Loss)-15.00K-23.00K1.00K
Other Non Operating Income (Expenses)-267.00K-77.00K-160.00K276.00K208.00K15.00K
EBT Excluding Unusual Items14.49M15.46M18.94M20.09M20.66M19.06M
Legal Settlements-1.51M-1.35M-2.14M
Pretax Income12.98M14.11M16.80M20.09M20.66M19.06M
Income Tax Expense2.33M2.82M2.93M3.45M4.19M4.27M
Net Income10.64M11.29M13.87M16.64M16.47M14.79M
Net Income to Common10.64M11.29M13.87M16.64M16.47M14.79M
Shares Outstanding (Basic)3.19M3.24M3.50M3.63M3.64M3.65M
Shares Outstanding (Diluted)3.19M3.24M3.50M3.64M3.64M3.66M
EPS (Basic)3.343.483.964.584.534.05
EPS (Diluted)3.343.483.964.574.524.04
Free Cash Flow14.32M14.60M21.64M20.34M20.65M
Free Cash Flow Per Share4.424.175.955.585.64
Dividend Per Share0.311.231.211.191.170.85
Gross Margin57.69%57.12%59.03%59.81%61.58%63.03%
Operating Margin34.27%33.12%38.46%33.40%37.85%38.49%
Profit Margin30.48%29.30%33.92%33.12%31.51%30.15%
Free Cash Flow Margin37.18%35.70%43.09%38.90%42.10%
EBITDA13.39M15.71M18.53M23.09M26.82M26.16M
EBITDA Margin38.34%40.78%45.30%45.98%51.30%53.33%
D&A For EBITDA1.42M2.95M2.79M6.32M7.03M7.28M
EBIT11.96M12.76M15.73M16.78M19.79M18.88M
EBIT Margin34.27%33.12%38.46%33.40%37.85%38.49%
Effective Tax Rate17.98%20.01%17.43%17.19%20.26%22.42%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents85.20M85.76M82.98M92.87M75.05M60.97M
Cash & Short-Term Investments85.20M85.76M82.98M92.87M75.05M60.97M
Accounts Receivable3.96M3.52M4.10M3.34M5.54M5.13M
Other Receivables2.00K-2.00K53.00K
Receivables3.96M3.52M4.09M3.39M5.54M5.13M
Inventory10.57M7.93M8.81M9.58M8.81M6.60M
Prepaid Expenses529.00K448.00K428.00K515.00K456.00K
Total Current Assets100.63M97.74M96.33M106.27M89.92M73.16M
Property, Plant & Equipment10.02M9.91M9.76M10.55M10.22M10.62M
Goodwill14.05M13.58M13.69M13.35M14.10M
Other Intangible Assets17.84M840.00K2.87M4.95M10.38M17.76M
Total Assets128.50M122.54M122.54M135.46M123.87M115.64M
Accounts Payable1.68M911.00K696.00K769.00K1.22M761.00K
Accrued Expenses3.06M2.47M3.10M3.36M4.20M2.85M
Current Portion of Leases60.00K
Current Income Taxes Payable-909.00K-153.00K327.00K337.00K36.00K
Other Current Liabilities68.00K111.00K257.00K204.00K96.00K
Total Current Liabilities4.74M2.60M3.76M4.71M5.96M3.75M
Long-Term Leases180.00K225.00K282.00K295.00K341.00K396.00K
Long-Term Deferred Tax Liabilities451.00K1.07M1.44M2.06M2.68M
Other Long-Term Liabilities698.00K1.26M1.68M
Total Liabilities5.22M3.27M5.11M7.14M9.62M8.50M
Common Stock123.28M32.00K33.00K36.00K36.00K37.00K
Additional Paid-In Capital594.00K251.00K841.00K
Retained Earnings128.65M129.30M138.34M126.01M115.31M
Comprehensive Income & Other-9.42M-11.91M-10.66M-12.04M-9.05M
Shareholders' Equity123.28M119.27M117.43M128.31M114.25M107.14M
Total Liabilities & Equity128.50M122.54M122.54M135.46M123.87M115.64M
Total Debt180.00K285.00K282.00K295.00K341.00K396.00K
Net Cash (Debt)85.02M85.47M82.69M92.57M74.71M60.58M
Net Cash Per Share26.6826.3823.6125.4520.5116.55
Filing Date Shares Outstanding3.18M3.19M3.28M3.59M3.63M3.65M
Total Common Shares Outstanding3.18M3.19M3.34M3.63M3.63M3.65M
Working Capital95.89M95.14M92.57M101.56M83.96M69.41M
Book Value Per Share38.8337.4335.2135.3531.4929.31
Tangible Book Value105.43M104.38M100.98M109.67M90.52M75.28M
Tangible Book Value Per Share33.2132.7630.2830.2224.9520.60
Land1.70M1.60M1.64M1.59M1.69M
Buildings14.38M13.54M13.91M13.60M14.17M
Machinery19.05M18.53M17.32M17.07M16.66M
Construction In Progress110.00K19.00K1.41M906.00K898.00K
Order Backlog731.00K1.89M3.65M5.61M4.96M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income11.29M13.87M16.64M16.47M14.79M
Depreciation & Amortization3.01M2.85M6.37M7.08M7.28M
Stock-Based Compensation373.00K256.00K225.00K183.00K166.00K
Provision & Write-off of Bad Debts367.00K-4.00K-33.00K30.00K24.00K
Other Operating Activities-659.00K-359.00K-693.00K-401.00K-92.00K
Change in Accounts Receivable338.00K-835.00K2.27M-511.00K-1.09M
Change in Inventory1.20M587.00K-670.00K-2.35M-485.00K
Change in Accounts Payable211.00K-73.00K-456.00K464.00K-23.00K
Change in Other Net Operating Assets-1.43M-1.48M-1.38M174.00K590.00K
Operating Cash Flow14.69M14.83M22.28M21.15M21.20M
Capital Expenditures-371.00K-230.00K-639.00K-809.00K-552.00K
Sale of Property, Plant & Equipment27.00K
Sale (Purchase) of Intangibles-5.00K-9.00K
Investing Cash Flow-371.00K-208.00K-639.00K-818.00K-552.00K
Issuance of Common Stock390.00K117.00K174.00K560.00K
Repurchase of Common Stock-8.36M-19.97M-2.50M
Common Dividends Paid-3.98M-4.26M-4.28M-3.16M-11.46M
Financing Cash Flow-12.34M-23.84M-4.17M-5.48M-10.90M
Foreign Exchange Rate Adjustments797.00K-677.00K339.00K-767.00K-362.00K
Net Cash Flow2.78M-9.89M17.82M14.08M9.38M
Free Cash Flow14.32M14.60M21.64M20.34M20.65M
Free Cash Flow Margin37.18%35.70%43.09%38.90%42.10%
Free Cash Flow Per Share4.424.175.955.585.64
Levered Free Cash Flow11.13M11.79M16.66M18.35M17.14M
Unlevered Free Cash Flow11.13M11.79M16.66M18.35M17.14M
Cash Income Tax Paid4.00M4.64M4.83M4.97M4.62M
Change in Working Capital317.00K-1.80M-233.00K-2.23M-1.01M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization216.14M179.28M208.48M305.68M364.68M365.09M
Enterprise Value131.12M95.25M120.33M217.77M295.52M301.11M
Last Close Price68.0855.2059.3679.8894.0992.37
PE Ratio20.3915.8815.0318.3822.1424.69
Forward PE17.8017.8017.8017.8017.80
PS Ratio6.194.655.106.096.977.44
PB Ratio1.751.501.772.383.193.41
P/TBV Ratio2.051.722.062.794.034.85
P/FCF Ratio18.8812.5214.2814.1217.9317.68
P/OCF Ratio18.2412.2014.0613.7217.2517.22
PEG Ratio1.191.191.191.191.19
EV/Sales Ratio3.752.472.944.345.656.14
EV/EBITDA Ratio9.796.066.499.4311.0211.51
EV/EBIT Ratio10.967.477.6512.9814.9315.95
EV/FCF Ratio11.456.658.2410.0614.5314.58
Debt / Equity Ratio0.000.000.000.000.000.00
Debt / EBITDA Ratio0.010.020.020.010.010.02
Debt / FCF Ratio0.020.020.010.020.02
Net Debt / Equity Ratio-0.69-0.72-0.70-0.72-0.65-0.56
Net Debt / EBITDA Ratio-6.35-5.44-4.46-4.01-2.79-2.32
Net Debt / FCF Ratio-5.97-5.66-4.28-3.67-2.93
Asset Turnover0.280.310.320.390.440.43
Inventory Turnover1.581.971.822.192.612.83
Quick Ratio18.8134.3623.1820.4413.5217.65
Current Ratio21.2337.6225.6422.5615.0919.54
Return on Equity (ROE)8.81%9.54%11.29%13.72%14.88%14.09%
Return on Assets (ROA)5.97%6.51%7.62%8.09%10.33%10.38%
Return on Invested Capital (ROIC)26.90%29.78%36.87%36.91%36.65%29.85%
Return on Capital Employed (ROCE)9.70%10.60%13.20%12.80%16.80%16.90%
Earnings Yield4.90%6.30%6.65%5.44%4.52%4.05%
FCF Yield5.30%7.99%7.00%7.08%5.58%5.66%
Dividend Yield1.82%2.18%1.93%1.41%1.16%0.86%
Payout Ratio37.14%35.29%30.70%25.74%19.20%77.53%
Buyback Yield / Dilution3.07%7.51%3.68%0.17%0.46%0.33%
Total Shareholder Return4.89%9.69%5.61%1.57%1.62%1.18%